Healthcare

At the time of writing this article, Optiscan Imaging Ltd (ASX:OIL) was trading at AUD 0.185, up 8.82% during today’s trading session. Optiscan is an Australian medical technology company developing microscopic imaging systems for digital pathology, surgery and other clinical applications. Recent activity has …

At the time of writing this article, Algorae Pharmaceuticals Ltd (ASX:1AI) was trading at AUD 0.009, up 5.88% during today’s trading session. Algorae is an Australian pharmaceutical company combining commercial medicineSupplywith research and development. Its operating model includes AlgoraeRx, which sources, registers and supplies …

At the time of writing this article, Control Bionics Ltd (ASX:CBL) was trading at AUD 0.063, up 5.00% during today’s trading session. Control Bionics is an Australian neurotechnology company developing non-invasive technologies that capture physiological signals and convert them into data and control inputs. …

At the time of writing this article, PYC Therapeutics Ltd (ASX:PYC) was trading at AUD 2.665, up 4.51% during today’s trading session. PYC Therapeutics is a clinical-stage biotechnology company developing RNA-based treatments for genetic diseases. Its proprietary drug-delivery platform combines RNA therapeutics with cell-penetrating …

At the time of writing this article, Healius Ltd (ASX:HLS) was trading at AUD 0.418, up 3.09% during today’s trading session. Healius is an Australian healthcare company focused primarily on pathology services, supported by its Agilex Biolabs operations. The company provides specialty pathology services …

At the time of writing this article, ImpediMed Limited (ASX:IPD) was trading at AUD 0.007, up 30.00% during today’s trading session. ImpediMed is a medical technology company focused on bioimpedance spectroscopy-based systems used to assess and monitor fluid status and body composition. Its commercial …

At the time of writing this article, Noxopharm Limited (ASX:NOX) was trading at AUD 0.063, up 6.78% during today’s trading session. Noxopharm is an Australian clinical-stage biotechnology company developing targeted therapies for chronic inflammation, autoimmune diseases and cancer. Its development activities are centred on …